Alex is an intellectual property disputes lawyer with thirteen years’ experience and a track record of obtaining successful outcomes for clients. He specialises in advising pharmaceutical companies on patent litigation and related matters and has a technical background in genetics.
Alex has represented some of the largest pharmaceutical companies in the world in patent disputes relating to blockbuster antiviral, autoimmunity and chemotherapy medicines. He has also advised on patent matters relating to antibody-drug conjugates, monoclonal antibody platforms and CRISPR gene-editing technology. He is experienced in preparing validity and infringement opinions, giving freedom-to-operate advice, advising on patenting and litigation strategy, conducting patent oppositions, coordinating litigation and patent office actions around the world, and managing the life cycles of medicines. Alex also has interests in personalised and psychedelic medicines.
Outside of life sciences, Alex has acted in patent litigation in the telecoms and engineering fields against opponents such as Apple, Nokia and Transocean. He has also represented clients in copyright, designs, trade marks and unfair competition litigation.
Alex’s career to date has been split between the UK and Australia, and he is qualified as a solicitor of England and Wales. He has previously worked for the top-tier IP law practices Bristows and Powell Gilbert in London and Allens in Melbourne. Alex has also served as IP Counsel at United Technologies. There, he supervised the drafting and prosecution of patent applications, giving him a broader perspective on patent matters. Alex joined Pearce IP from Jones Day.
Before pursuing a career in law, Alex spent two years performing laboratory research in the biotechnology sector.
Australian Law Awards (Lawyers Weekly)
Winner – Intellectual Property Team of the Year 2021
World Intellectual Property Review
WIPR Leader 2021
By 2027, be the premier life sciences IP practice in Australia.